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Evaluating the Impact of a Pediatric Asthma
Clinical Pathway
Joseph Stidham, Liborio Larussa, MD
Lehigh Valley Health Network, Allentown, PA

Background

Results

Clinical Pathways are an increasingly common feature
of modern healthcare. Introducing standardization
of thought between healthcare providers and nonprovider members of the healthcare team allows for
greater consistency of care and – ideally – improved
patient outcomes and satisfaction. This fall the
inpatient pediatric department at Lehigh Valley Health
Network is implementing a clinical pathway around
treatment of asthma inpatients. The objective of
the pathway is to eliminate inconsistency between
providers and encourage evidence based practice,
while simultaneously increasing patient understanding
and reinforcing staff teamwork competencies. It does
this in a number of ways. First, it utilizes an algorithm
for scoring patients and determining the frequency of
therapy with beta-agonists and corticosteroids. The
pathway also standardizes treatment with multi-dose
inhalers (MDI) rather than nebulizer therapy (when
possible). Finally, the pathway involves respiratory
therapy with every patient admitted for asthma. This
project sought to assess the success of the pathway in
improving outcomes and reducing waste in the care of
pediatric asthma patients.

The patient volumes for the pre and post-pathway periods were comparable at
108 and 93 patients respectively. We found that the ALOS in the full admission
group fell by 0.48 days (p=0.0002) from 3.8 to 3.2, and rose in the observation
group by 0.09 days (p=0.062) from 1.16 to 1.25. When pooled, the overall
ALOS fell by 0.67 days (p=0.0003) from 2.92 to 2.25 (Fig 1). This shows a
statistically significant decrease in the ALOS during inpatient admissions and
overall admissions when pooled with observations. The difference in ALOS of
observations is not statistically significant. In the pre-pathway period 38.9% of
asthma patients received respiratory consults (Table 1).
Figure 1: ALOS of Pediatric Inpatients 2015

Table 1: Pediatric Asthma Volume and
Respiratory Consults
Jan-Dec 2015
Inpt

Obv

Total

Respiratory
Consults

January

14

2

16

6

February

16

5

21

5

March

8

9

17

4

April

11

5

16

4

May

13

9

22

8

June

10

6

16

10

July

3

2

5

5

August

4

5

9

September

9

14

23

October

8

12

20

November

14

9

23

December

7

6

13

Month/CY

Figure 2: Pediatrics Asthma Pathway - Inpatient

Methodology
We did this by measuring the average length of
stay (ALOS) of asthma inpatients for the six months
before and the six months after the implementation
of the pathway. We selected patients based on
their discharge diagnosis and time of discharge. In
order to avoid any confounding of the data based on
seasonal variation, we compared the volume of asthma
patients in each of these time periods. We divided
these patients into those admitted for observation and
those admitted for a full inpatient admission. We also
examined the frequency of respiratory therapy consults
on asthma patients during the period in question.

Conclusions and Future Implications
The pathway that led to these results was not just a simple algorithm, but
was rather a comprehensive suite of adjustments to the status quo of asthma
care, including changes to the type of therapy, the frequency, the involvement
of respiratory therapists, and the criteria for discharge. It is important to note
that the pathway was not a static document during the experimental period,
but rather was subject to continuous improvement beginning immediately after
implementation. Continuing to improve patient care based on interdisciplinary
feedback and objective results is essential to the successful implementation
of clinical pathways. This experiment shows that this clinical pathway is
improving the care of patients while simultaneously reducing healthcare
costs on our inpatient unit. The improvements can be attributed to increasing
uniformity of care, transitioning to MDI therapy, and increasing involvement
of respiratory therapy. One significant limitation to this experiment is the fact
that data on readmissions during the pathway period were not available, which
could change the conclusions drawn from these data.
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